The Readout Loud

350 Episodes

1. 268: Biogen's sticky situation, Wegovy's risks, & biotech insider trading

   Published: 7/27/2023
2. 267: BridgeBio's big week, Lilly's Alzheimer's data, & succession at Stanford

   Published: 7/20/2023
3. 266: Wegovy in the brain, pivotal Alzheimer's data, & pulling Threads

   Published: 7/13/2023
4. 265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

   Published: 6/29/2023
5. 264: Messy PBM conflicts, debatable vaccines, & the future of flu season

   Published: 6/22/2023
6. 263: Biogen's messy board, Laronde's data problem, & the downside of a boom

   Published: 6/15/2023
7. 262: Merck v. USA, the best of ASCO, and Leqembi at the FDA

   Published: 6/8/2023
8. 261: Fake medical devices, real cancer drugs, & curious Ozempic effects

   Published: 6/1/2023
9. 260: ChatGPT in medicine, a boom in weight loss pills, & Sarepta at the FDA

   Published: 5/25/2023
10. 259: The FTC v. Amgen, Sarepta's future, & Galapagos' turnaround

    Published: 5/18/2023
11. 258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry

    Published: 5/11/2023
12. 257: Lilly's Alzheimer's success, a milestone FDA approval, & Moderna's shrinking business

    Published: 5/4/2023
13. 256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

    Published: 4/27/2023
14. 255: Sarepta's pivotal moment, biotech's big week, & the future of Covid boosters

    Published: 4/20/2023
15. 254: The legal battle over abortion, an FDA 'bully pulpit' and Moderna's future

    Published: 4/13/2023
16. 253: Illumina’s boardroom intrigue, the next big Alzheimer’s readout, & J&J’s creative lawyers

    Published: 4/6/2023
17. 252: Biotech's monkey shortage, the broken generics market, & conference cancel culture

    Published: 3/30/2023
18. 251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster

    Published: 3/23/2023
19. 250: SVB's long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

    Published: 3/16/2023
20. 249: Robert Califf on how drugs get approved, plus the nascent revolution in obesity

    Published: 3/9/2023